Antibe Therapeutics Inc (ATE.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 2,499 | 2,068 | 2,543 | 2,208 | 2,235 |
| Cost of Goods | 1,465 | 1,240 | 1,559 | 1,347 | 1,351 |
| Gross Profit | 1,034 | 828 | 984 | 861 | 884 |
| Operating Expenses | 4,232 | 3,042 | 3,479 | 2,734 | 2,281 |
| Operating Income | -3,198 | -2,214 | -2,495 | -1,873 | -1,397 |
| Interest Expense | 111 | 122 | 91 | 470 | 247 |
| Other Income | 8 | 10 | -79 | -36 | 0 |
| Pre-tax Income | -3,301 | -2,325 | -2,664 | -2,379 | -1,643 |
| Income Tax | 2 | 131 | -2 | 5 | -18 |
| Net Income Continuous | -3,303 | -2,456 | -2,662 | -2,384 | -1,625 |
| Net Income | $-3,303 | $-2,456 | $-2,662 | $-2,384 | $-1,625 |
| EPS Basic Total Ops | -0.10 | -0.10 | -0.10 | -0.20 | -0.10 |
| EPS Basic Continuous Ops | -0.10 | -0.10 | -0.10 | -0.20 | -0.10 |
| EPS Diluted Total Ops | -0.10 | -0.10 | -0.10 | -0.20 | -0.10 |
| EPS Diluted Continuous Ops | -0.10 | -0.10 | -0.10 | -0.20 | -0.10 |
| EBITDA(a) | $-3,094 | $-2,106 | $-2,477 | $-1,813 | $-1,298 |